Loading...

APC Streptavidin

Pricing & Availability
Regulatory Status
RUO
Other Names
Streptavidin-Allophycocyanin, SAv-APC
Ave. Rating
Submit a Review
Product Citations
publications
APC_Streptavidin_Antibody_042123
Human peripheral blood lymphocytes were stained with APC streptavidin alone (open histogram) or Biotin anti-human CD3 (clone UCHT1) followed by (APC) Streptavidin (filled histogram).
  • APC_Streptavidin_Antibody_042123
    Human peripheral blood lymphocytes were stained with APC streptavidin alone (open histogram) or Biotin anti-human CD3 (clone UCHT1) followed by (APC) Streptavidin (filled histogram).
See APC spectral data
Cat # Size Price Quantity Check Availability Save
405207 100 µg 96€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Streptavidin binds to biotin with high affinity. Streptavidin-APC is useful for detecting biotinylated antibodies. The excitation of APC by 600-635 nm laser light induces a fluorescence emission maximum of 660 nm.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human, Mouse, Rat, All Species
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
Streptavidin is conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml (concentration relates to the Streptavidin only component of the conjugate)
Storage & Handling
The Streptavidin-APC solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

ICFC - Verified
Recommended Usage

Each lot of this Streptavidin-APC is quality control tested by immunofluorescent staining with flow cytometric analysis. The concentration provided is based upon molecular mass of streptavidin independent of any additional molecular mass that might be added by the APC conjugation. For immunofluorescent staining, the recommended use of this reagent is ≤ 0.125 µg per 106 cells in 100 µl staining volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Streptavidin-APC is useful as a second step reagent for indirect immunofluorescent staining, when used in conjunction with biotinylated primary antibodies. The average molecular weight of Streptavidin-APC is 320 kD and Streptavidin alone is 52 kD.

Application References
  1. Kamimura D, et al. 2006. J. Immunol. 177:306.
  2. Andoniou CE, et al. 2005. Nature Immunology 6:1011.
  3. Chou WC,et al.2006.Blood108:3005. PubMed
  4. Malagolini N, et al. 2009. Glycobiology. 19:172. PubMed
  5. Kroeger KM, et al. 2009. J. Leukocyte Biol. PubMed
  6. Imada M, et al. 2009. Int. Immunol. 21:1151. PubMed
  7. Yi Y, et al. 2010 J. Biol Chem. 285:21233. PubMed
  8. King IL, et al. 2010. J. Immunol. 185:6138. PubMed
  9. Yokoyama T, et al. 2011. Int Immunol. PubMed
  10. Rusert P, et al. 2011. J. Exp Med. 208:1419. PubMed
  11. Bollig N, et al. 2012. PNAS. 109:8664. PubMed
  12. Nguyen V, et al. 2012. J. Immunol. 189:1081. PubMed
  13. Jager NA, et al. 2012. J Nucl Med. 53:1229. PubMed
  14. Liberman AC, et al. 2012. Mol Immunol. 50:220. PubMed
  15. Ogawa H, et al. 2012. Biochem Biophys Res Commun. 420:114. PubMed
  16. Ludin A, et al.2012. Nat Immunol. 13:1072. PubMed
  17. Sugiura D, et al. 2012. PLoS One. 7:e44770. PubMed
  18. Tani-Ichi S, et al. 2012. PNAS. 110:612. PubMed
  19. Jin L, et al. 2013. PNAS. 110:3907. PubMed
  20. Ota T, et al. 2013. J. Immunol. 191:3179. PubMed
  21. Fu X, et al. 2013. PNAS. 110:17982. PubMed
  22. Ryan SO, et al. 2014. Glycobiology. 24:362. PubMed
  23. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  24. Pilling D, et al. 2014. PLoS One. 9:93730. PubMed
  25. Matthews JA, et al. 2014. PLoS One. 9:97707. PubMed
  26. Owen KA, et al. 2014. PLoS Pathog. 10:1004159. PubMed
  27. Duek A, et al. 2014. Blood. 123:3943. PubMed
  28. Madireddi S, et al. 2014. J Exp Med. 211:1433. PubMed
  29. Skogberg G, et al. 2014. J Immunol. 193:2187. PubMed
  30. Lundberg P, et al. 2014. J Exp Med. PubMed
  31. Martin RK, et al. 2014. PLoS One. 9:110609. PubMed
  32. Rai S, et al. 2014. PLoS One. 9:109441. PubMed
  33. Santoyo-Ramos P, et al. 2014. PLoS One. 9:112580. PubMed
  34. Jager NA, et al. 2014. J Nucl Med. 55:1945. PubMed
  35. Kong S, et al. 2014. J Immunol. 193:5515. PubMed
  36. Cabrera-Perez J, et al. 2015. J Immunol. 194:1609. PubMed
  37. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  38. Kim Yu, et al. 2015. PLoS One. 10:120294. PubMed
  39. Zhang L, et al. 2015. J Immunol. 194:5243. PubMed
Product Citations
  1. Bradley CP et al. 2017. Cell host & microbe. 22(5):697-704 . PubMed
  2. Perruzza L, et al. 2019. Sci Rep. 9:9315. PubMed
  3. Cohen–Khait R, et al. 2017. Structure. 25:1867. PubMed
  4. Preece R, et al. 2020. Gene Ther. 451:27. PubMed
  5. Madireddi S, et al. 2014. J Exp Med. 211:1433. PubMed
  6. Suzuki M, et al. 2015. J Immunol. 195: 1273-1281. PubMed
  7. Goel RR, et al. 2022. Cell. 185:1875. PubMed
  8. Sugimoto M, et al. 2022. DNA Res. 29: . PubMed
  9. Nutalai R, et al. 2022. Cell. 185:2116. PubMed
  10. Singh S, et al. 2022. iScience. 25:104549. PubMed
  11. Gargaro M, et al. 2022. Immunity. 55:1032. PubMed
  12. Scharf L, et al. 2023. JCI Insight. 8: . PubMed
  13. Cao Y, et al. 2023. Nature. 614:521. PubMed
  14. Tanaka T, et al. 2023. Nat Immunol. 24:439. PubMed
  15. Hernandez SPA, et al. 2023. Front Immunol. 13:1035344. PubMed
  16. Pušnik J, et al. 2023. Nat Commun. 14:572. PubMed
  17. Gon Y, et al. 2023. PLoS One. 18:e0279389. PubMed
  18. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  19. Dickerson KM, et al. 2022. Blood Cancer Discov. 3:240. PubMed
  20. Lopez R, et al. 2022. Nat Biotechnol. 40:1360. PubMed
  21. White Z, et al. 2022. Blood Cells Mol Dis. 97:102688. PubMed
  22. Chen HY, et al. 2022. Elife. 11:. PubMed
  23. Parry H, et al. 2022. Cell Rep Med. 3:100739. PubMed
  24. Vyasamneni R, et al. 2023. Cell Rep Methods. 3:100388. PubMed
  25. Nihei Y, et al. 2023. Sci Adv. 9:eadd6734. PubMed
  26. Koutsakos M, et al. 2023. Immunity. 56:879. PubMed
  27. García-Vega M, et al. 2023. iScience. 26:106562. PubMed
  28. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  29. Hie B, et al. 2023. Nat Biotechnol. . PubMed
  30. Li X, et al. 2023. Nat Commun. 14:2929. PubMed
  31. Lan Y, et al. 2023. iScience. 26:106817. PubMed
  32. Malagolini N, et al. 2009. Glycobiology. 0.911111111. PubMed
  33. Wang L, et al. 2019. Cell Rep. 29:1848. PubMed
  34. Tarban N, et al. 2022. Cells. 11:. PubMed
  35. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  36. Schneider C, et al. 2018. Cell. 174:271. PubMed
  37. Proietti M, et al. 2019. Nat Commun. 10:250. PubMed
  38. Koh CH, et al. 2020. Cancer Immunol Res. 8:698. PubMed
  39. Georgiadis C, et al. 2021. Leukemia. . PubMed
  40. Viborg N, et al. 2019. Oncoimmunology. 8:e1663107. PubMed
  41. Pazina T, et al. 2019. Cancer Immunol Res. 7:1633. PubMed
  42. Temming AR, et al. 2021. Front Immunol. 12:594773. PubMed
  43. Blake SJ, et al. 2021. Cell Rep Med. 2:100464. PubMed
  44. Sarkar R, et al. 2021. Bio Protoc. 11:e4255. PubMed
  45. Hou S, et al. 2021. Sci Immunol. 6:eabg9433. PubMed
  46. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  47. Ota T, et al. 2013. J Immunol. 191:3179. PubMed
  48. Santoyo-Ramos P, et al. 2014. PLoS One. 9:112580. PubMed
  49. Ludin A, et al. 2012. Nat Immunol. 13:1072. PubMed
  50. Jager N, et al. 2012. J Nucl Med. 53:1222. PubMed
  51. Kimura T, et al. 2019. Am J Physiol Lung Cell Mol Physiol. 317:L271. PubMed
  52. da Mota JB, et al. 2020. J Leukoc Biol. 108:1239. PubMed
  53. Niewolik D, et al. 2022. Nucleic Acids Res. 50:2096. PubMed
  54. Io S, et al. 2021. STAR Protoc. 2:100921. PubMed
  55. Biffi G, et al. 2018. Cancer Discov. 2:282. PubMed
  56. Lebert-Ghali C, et al. 2017. Exp Hematol. 10.1016/j.exphem.2017.03.003. PubMed
  57. Yamanaka S, et al. 2021. STAR Protocols. 2(1):100314. PubMed
  58. J L, et al. 2016. Sci Rep. 6:30904. PubMed
  59. Gaudreault V, et al. 2015. PLoS One. 10: e0140805. PubMed
  60. Jager N, et al. 2014. J Nucl Med. 55:1945. PubMed
  61. Catapano M, et al. 2020. J Invest Dermatol. 140:816. PubMed
  62. Rusert P, et al. 2011. J Exp Med. 208:1419. PubMed
  63. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  64. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  65. Mathews J, et al. 2014. PLoS One. 9:97707. PubMed
  66. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  67. Jin L, et al. 2016. Stem Cell Res. 16:40-53. PubMed
  68. Palm A, et al. 2016. Sci Rep. 10.1038/srep20531. PubMed
  69. Liu C, et al. 2022. Cell Host Microbe. 30:53. PubMed
  70. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
  71. Cao Y, et al. 2022. Nature. :. PubMed
  72. Sato Y, et al. 2021. J Clin Invest. Online ahead of print. PubMed
  73. Toulmin SA, et al. 2021. Nat Commun. 12:3993. PubMed
  74. Barcala Tabarrozzi A, et al. 2016. Sci Rep. 6:36646. PubMed
  75. Kong S, et al. 2014. J Immunol. 193:5515. PubMed
  76. Yokoyama T, et al. 2011. J Immunol. 208:885. PubMed
  77. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  78. Duek A, et al. 2014. Blood. 123:3943. PubMed
  79. Bollig N, et al. 2012. Proc Natl Acad Sci U S A. 109:8664. PubMed
  80. Yi Y, et al. 2010. J Biol Chem. 285:21233. PubMed
  81. Chou W, et al. 2006. Blood. 108:3005. PubMed
  82. Tashita C, et al. 2020. World J Gastroenterol. 26:918. PubMed
  83. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  84. Cao Y, et al. 2022. Nature. 602:657. PubMed
  85. Kakizaki M, et al. 2021. Cell Death Dis. 12:1010. PubMed
  86. Calés C, et al. 2016. Mol Cell Biol. 36: 900 - 912. PubMed
  87. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  88. Hansen UK, et al. 2020. Front Immunol. 11:373. PubMed
  89. Tani-ichi S, et al. 2012. Proc Natl Acad Sci U S A. 110:612. PubMed
  90. Wang L, et al. 2022. Nat Commun. 13:4709. PubMed
  91. Han X, et al. 2017. Mol Ther. 25(1):274-284. PubMed
  92. Hao Y, et al. 2020. J Biol Chem. . PubMed
  93. Parikh BA, et al. 2020. Cell Rep. 32:107969. PubMed
  94. Ryan S, et al. 2014. Glycobiology. 24:262. PubMed
  95. Kunitomi A, et al. 2022. Cell Rep Methods. 2:100317. PubMed
  96. Sugiura D, et al. 2012. PLoS One. 7:e44770. PubMed
  97. Schoeler K, et al. 2019. FEBS J. 10.1111/febs.14934. PubMed
  98. Mizoguchi I, et al. 2020. J Clin Invest. 130:6124. PubMed
  99. Locke F, et al. 2017. Mol Ther. 25(1):285-295. PubMed
  100. Jennings R, et al. 2016. Int Immunol. 28: 503 - 512. PubMed
  101. Morita N, et al. 2016. Innate Immunity. 10.1177/1753425916672312. PubMed
  102. Rai S, et al. 2014. PLoS One. 9:109441. PubMed
  103. Owen K, et al. 2014. PLoS Pathog. 10:1004159. PubMed
  104. Nguyen V, et al. 2012. J Immunol. 189: 1081. PubMed
  105. Jin L, et al. 2013. Proc Natl Acad Sci U S A. 110:3907. PubMed
  106. Audemard-Verger A, et al. 2017. J Immunol. 10.4049/jimmunol.1700430. PubMed
  107. Hermann BP, et al. 2018. Cell Rep. 25:1650. PubMed
  108. Van Gool F, et al. 2019. Immunity. 50:362. PubMed
  109. James KR, et al. 2020. Nat Immunol. 1.113194444. PubMed
  110. Friedrich SK, et al. 2021. Pathogens. 10: . PubMed
  111. Grioni M, et al. 2021. Blood Adv. 5:2817. PubMed
  112. Ogawa H, et al. 2012. Biochem Biophys Res Commun. 420:114. PubMed
  113. Delacher M, et al. 2020. Immunity. 52:295. PubMed
  114. Pascual G, et al. 2021. Nature. 599:485. PubMed
  115. Guichard V, et al. 2017. Elife. 6:e27215. PubMed
  116. Saini SK, et al. 2021. Sci Immunol. 6:. PubMed
  117. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  118. Zhang L, et al. 2015. J Immunol. 194:5423. PubMed
  119. Skogberg G, et al. 2014. J Immunol. 193:2187. PubMed
  120. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  121. Jiang H, et al. 2011. PLoS One. 6:e27464. PubMed
  122. Collins DR, et al. 2021. Immunity. 54:2372. PubMed
  123. Dejnirattisai W, et al. 2021. Cell. 2183:184. PubMed
  124. Pilling D, Gomer R 2014. PLoS One. 9:93730. PubMed
  125. Larcombe-Young D, et al. 2022. STAR Protoc. 3:101414. PubMed
  126. King I, et al. 2010. J Immunol. 185:6138. PubMed
  127. Tuekprakhon A, et al. 2022. Cell. 185:2422. PubMed
  128. Kim SP, et al. 2022. Cancer Immunol Res. :OF1. PubMed
  129. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  130. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  131. Lundberg P, et al. 2014. J Exp Med. 211:2213. PubMed
  132. Budai Z, et al. 2021. Cells. 10:. PubMed
  133. Bainter W, et al. 2021. Sci Immunol. 6:eabf6723. PubMed
  134. Martin R, et al. 2014. PLoS One. 9:110609. PubMed
  135. Koide S, et al. 2022. iScience. 25:103603. PubMed
  136. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  137. Gerdes P, et al. 2022. Nat Commun. 13:7470. PubMed
  138. Yewdell WT, et al. 2021. Cell Rep. 37:109961. PubMed
  139. Nguyen NT, et al. 2021. Nat Nanotechnol. 16:1424. PubMed
  140. Kosti P, et al. 2021. STAR Protocols. 2:100723. PubMed
  141. Liberman A, et al. 2012. Mol Immunol. 50:220. PubMed
  142. GR N, et al. 2012. PLoS One. 7:e39045. PubMed
  143. Dyson MR, et al. 2020. MAbs. 12:1829335. PubMed
  144. Mazor Y, et al. 2017. Sci Rep. 7:40098. PubMed
  145. Wan X, Thomas J, Unanue E 2016. J Exp Med. 213: 967 - 978. PubMed
  146. Seenappa LM, et al. 2022. NPJ Vaccines. 7:128. PubMed
  147. Kroeger K, et al. 2009. J Leukoc Biol. 86:769. PubMed
  148. Zahradník J, et al. 2021. ACS Synth Biol. Online ahead of print. PubMed
  149. Chen Y, et al. 2021. Cancer Res Treat. Online ahead of print. PubMed
  150. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  151. Pedersen NW, et al. 2019. Nat Commun. 10:837. PubMed
  152. Nagatake T, et al. 2019. Mucosal Immunol. 12:p1082. PubMed
  153. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  154. Wang W, et al. 2020. STAR Protoc. 1:100218. PubMed
  155. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  156. Tripathi S, et al. 2016. Proc Natl Acad Sci U S A. 113: 1555 - 1564. PubMed
  157. Hauser J, et al. 2016. Mol Immunol. 80:78-90. PubMed
  158. Holm JS, et al. 2022. Nat Commun. 13:1935. PubMed
  159. Spanier J, et al. 2016. Nat Commun. 7:11804. PubMed
  160. Tagawa M, et al. 2016. PLoS One. 11: 0150030. PubMed
  161. Fu X, et al. 2013. Proc Natl Acad Sci U S A. 110:17892. PubMed
  162. Fichtner ML, et al. 2022. Acta Neuropathol Commun. 10:154. PubMed

Related FAQs

There are no FAQs for this product.
Go To Top Version: 5    Revision Date: 04-21-2023

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account